Rewriting Life Big Pharma Doubles Down on CRISPR for New Drugs A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body. by Mike Orcutt 2016-01-13T00:00:00-05:00
Rewriting Life Roche Takes Control of Innovative DNA Test Maker Foundation Medicine A $1 billion deal for tests that can steer patients to the right drug. by Antonio Regalado 2015-01-12T15:51:00-05:00
Business Impact Big Pharma Opens Up Its Big Data Normally super-secretive, pharmaceutical companies are opening up in the hopes of jump starting drug development. by Arlene Weintraub 2014-07-21T12:00:00-04:00
Rewriting Life Cancer Drugs Should Cost Less, Say Doctors Doctors argue that some drug companies are charging too much for their cancer drugs, to the detriment of patients. by Susan Young Rojahn 2013-04-29T12:41:44-04:00
Rewriting Life A New Setback for Alzheimer's Drugs A compound that attacks amyloid plaques fails to help patients, raising questions about similar therapeutics. by Susan Young Rojahn 2012-08-09T00:00:00-04:00
Rewriting Life Company Decodes Cancers to Target Treatment By analyzing tumors, Foundation Medicine helps oncologists, pharma companies, and researchers combat the disease. by Emily Singer 2011-11-03T00:00:00-04:00
